Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. F. Rabe (Leiden, The Netherlands). Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD. Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers

Member's Comments

No comment yet.

Related content which might interest you: Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Are current treatment recommendations suited to elderly patients with asthma or COPD? Source: Eur Respir Mon; 2009: 43: 267–285 Year: 2009 Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 903-908 Year: 2001 A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013 Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 243-244 Year: 2002 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation Year: 2006 ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations Source: Guideline 2022 Year: 2021 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Exacerbations and associated health-care cost in patients with chronic obstructive pulmonary disease (COPD) in general practice. Results from the COOPT trial Source: Eur Respir J 2002; 20: Suppl. 38, 398s Year: 2002 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Monitoring of COPD. A review of current guidelines‘ recommendations Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014